Compounds for the treatment of cancer

Number of patents in Portfolio can not be more than 2000

United States of America Patent

PATENT NO 11066400
APP PUB NO 20180170923A1
SERIAL NO

15851188

Stats

ATTORNEY / AGENT: (SPONSORED)

Importance

Loading Importance Indicators... loading....

Abstract

See full text

The present invention relates to a FoxM1 gene splicing modifier selected from a compound of formula (I) or of formula (VI)

Loading the Abstract Image... loading....

First Claim

See full text

Family

Loading Family data... loading....

Patent Owner(s)

  • HOFFMANN-LA ROCHE, INC.

International Classification(s)

Inventor(s)

Inventor Name Address # of filed Patents Total Citations
Metzger, Friedrich Freiburg, DE 27 70
Ratni, Hasane Habsheim, FR 128 470

Cited Art Landscape

Load Citation

Patent Citation Ranking

Forward Cite Landscape

Load Citation

Maintenance Fees

Fee Large entity fee small entity fee micro entity fee due date
3.5 Year Payment $1600.00 $800.00 $400.00 Jan 20, 2025
7.5 Year Payment $3600.00 $1800.00 $900.00 Jan 20, 2029
11.5 Year Payment $7400.00 $3700.00 $1850.00 Jan 20, 2033
Fee Large entity fee small entity fee micro entity fee
Surcharge - 3.5 year - Late payment within 6 months $160.00 $80.00 $40.00
Surcharge - 7.5 year - Late payment within 6 months $160.00 $80.00 $40.00
Surcharge - 11.5 year - Late payment within 6 months $160.00 $80.00 $40.00
Surcharge after expiration - Late payment is unavoidable $700.00 $350.00 $175.00
Surcharge after expiration - Late payment is unintentional $1,640.00 $820.00 $410.00